8 results match your criteria: "Cancer Institute (Women's India Association)[Affiliation]"
Indian J Surg Oncol
March 2024
Department of Medical Oncology, Cancer Institute Women's India Association (WIA), Adyar, Chennai, Tamil Nadu India.
Unlabelled: Ewing's sarcoma family of tumors (EWSFT) is common in the second decade of life. Achieving good outcomes in EWSFT requires a multimodality approach. We report the clinico-pathological features, treatment, and survival outcomes of patients with EWSFT treated at our center.
View Article and Find Full Text PDFA A Pract
December 2022
Surgical Oncology, Cancer Institute (Women's India Association), Chennai, India.
A 50-year-old man with muscle-invasive bladder cancer was scheduled for a robotic radical cystectomy. Four hours into the surgery, his electrocardiogram showed rhythm disturbances. Arterial blood gas analysis showed a serum potassium concentration of 6.
View Article and Find Full Text PDFLeuk Lymphoma
March 2022
Departments of Oncopathology, Cancer Institute (Women's India Association), Chennai, India.
The major challenge in minimal residual disease MRD) detection is the antigen modulation in post treated samples restraining the use of diagnostic immunophenotypic (IP) signature of leukemic blasts for MRD detection. The IP expression of 10 antigens in 167 children diagnosed as B-acute lymphoblastic leukemia B-ALL) in comparison to hematogones and the extent of immunomodulation in 60 post treated MRD positive cases were studied. Upregulation was the predictable shift noted in antigens like CD73, CD86, CD19, CD20 and CD45 which was statistically significant for all except CD45.
View Article and Find Full Text PDFGlob Health Action
September 2018
a Department of Operational Research , International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office , New Delhi , India.
Background: A large state-wide tobacco survey was conducted using modified version of pretested, globally validated Global Adult Tobacco Survey (GATS) questionnaire in 2015-22016 in Tamil Nadu, India. Due to resource constrains, data collection was carrid out using paper-based questionnaires (unlike the GATS-India, 2009-2010, which used hand-held computer devices) while data entry was done using open access tools. The objective of this paper is to describe the process of data entry and assess its quality assurance and efficiency.
View Article and Find Full Text PDFJ Cancer Res Ther
March 2015
Department of Pathology, Cancer Institute (Women's India Association), Adyar, Chennai, India.
A few cases with bilateral renal enlargement in acute lymphoblastic leukemia (ALL) are reported in literature. In this article, we report an unusual case of ALL in an adult presenting as multiple lesions in both kidneys and multiple bone lesions.
View Article and Find Full Text PDFAnn Maxillofac Surg
July 2013
Department of Surgical Oncology, Cancer Institute (Women's India Association), Adyar, Chennai, Tamil Nadu, India.
Primitive neuroectodermal tumor (PNET) is a broad term that includes a wide array of lesions with varying differentiating potential affecting both the central and peripheral nervous system. Peripheral PNET (pPNET), a variant of PNET, is known to arise in many places throughout the body; involvement of the mandible is however rare. A review of the scientific literature describes only seven reports of pPNET to be arising from the mandible.
View Article and Find Full Text PDFCancer Genet
May 2013
Department of Molecular Oncology, Cancer Institute (Women's India Association), Chennai, India.
Sclerostin domain containing 1 (SOSTDC1) is reportedly down-regulated in various cancers. Our purpose was to study whether epigenetic mechanisms were involved in the down-regulation of expression in gastric cancer. Expression analysis of SOSTDC1 in gastric cancer cell lines indicated mRNA down-regulation.
View Article and Find Full Text PDFHematol Oncol Stem Cell Ther
April 2012
Department of Medical Oncology, Cancer Institute (Women's India Association), Tamil Nadu, India.
Background And Objectives: Bendamustine has been recently approved for the treatment of low-grade lymphoproliferative disorders. There is little data on the effectiveness or toxicity of this drug outside the trial setting. This is the first report on the use of bendamustine from the Indian subcontinent.
View Article and Find Full Text PDF